Skip to main content


Weitere Artikel dieser Ausgabe durch Wischen aufrufen

01.03.2017 | case report | Ausgabe 5-6/2017 Open Access

Wiener klinische Wochenschrift 5-6/2017

Bone microarchitecture deteriorations and a fragility fracture in a patient with beta and alpha heterozygous thalassemia: a case report

Wiener klinische Wochenschrift > Ausgabe 5-6/2017
MD Xaver Feichtinger, MD Roland Kocijan, MD Heinrich Resch, MD Christian Muschitz


To date there are few studies that have investigated bone mineral density (BMD) and markers of bone metabolism in patients with thalassemia minor form. None of the previous trials presented bone structure analysis in the patient populations. We present the case of a 24-year-old Turkish woman with heterozygous beta and alpha thalassemia who sustained a low-trauma fracture of the inferior pubic ramus. Despite normal markers of bone metabolism, the dual X‑ray absorptiometry (DXA) showed decreased areal bone mineral density. Furthermore, severely reduced bone structure parameters and reduced volumetric bone mineral density was assessed by high-resolution peripheral quantitative computed tomography (HR-pQCT). Due to these diagnostic findings at time of peak bone mass, an osteoanabolic therapy with teriparatide for 24 months was initiated. The findings concerning BMD and bone structure in this patient can be seen as caused by the beta and alpha thalassemia.

Unsere Produktempfehlungen

Abo für kostenpflichtige Inhalte

Über diesen Artikel

Weitere Artikel der Ausgabe 5-6/2017

Wiener klinische Wochenschrift 5-6/2017 Zur Ausgabe